Submission to FTC on the Role of Intellectual Property
A Chinese twist in the tale involving Hepatitis C drug Sofosbuvir
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Would reforming the U.S. patent system help to lower drug prices?
Reality check on PBMs and drug costs
Patent abuse driving high drug prices, non-profit claims
Brainstorm Health: BeiGene IPO, Amerisource CEO on Amazon, California Data Privacy Law
Axios Vitals: Patents = profits (Article 3)
AbbVie faces hepatitis C patent challenge in India
Brief: AbbVie Hepatitis C Treatment Patents Challenged In India For Evergreening